Social News
Written by: Wang Jieen
2021-02-18 11:22
The last update date: 2021-02-18 11:22
The Food and Health Bureau announced today (18th) that the Commissioner, Mr. Chen Zhaoshi, has approved Kexing’s new crown vaccine for emergency use in Hong Kong under the Prevention and Control of Diseases (Use of Vaccines) Regulations today. The relevant approval will take effect today.
The bureau also stated that according to the information provided by the vaccine supplier, the first batch of about 1 million doses of Kexing vaccine to be supplied to Hong Kong will soon arrive in Hong Kong. After the government receives the vaccine and completes the necessary quality inspection procedures, it will start as soon as possible. A territory-wide vaccination programme.
▼ Kexing vaccine needs seven major steps from the laboratory to the market▼
+9
+9
+9
The Vaccine Advisory Committee said yesterday that it recommends the Hong Kong government to use the Mainland Coxing vaccine.
According to the Food and Health Bureau today, the Secretary has referred to the advice of the Advisory Expert Committee and considered the threat posed to public health by the new crown pneumonia. He believes that the recognition is necessary and in the public interest, and that he has exercised the provisions of Article 3 of the Regulation. The right to recognize Kexing’s new crown vaccine for specified purposes in Hong Kong.
▼Kexing, BioNTech/Fosun, AstraZeneca vaccine protection rate and side effects▼
+2
+2
+2
To continue to submit the latest clinical data, the
bureau also pointed out that in order to ensure the continued safety, effectiveness and quality assurance of the vaccine, the bureau director attached conditions to the above recognition, including requiring applicants to implement relevant risk management plans and continue to submit the latest clinical Data, laboratory analysis certificates for each batch, and timely update of quality documents, etc.
The bureau stated that the government will also continue to follow up the emergency use approval and supply schedules for the remaining vaccines purchased in Hong Kong, and make preparations for related vaccination arrangements.
The government will also continue to follow the vaccine procurement strategy and pre-procure other new crown vaccines that meet the safety, efficacy and quality requirements, including those that are still in the development stage, to ensure that the citizens of Hong Kong have different vaccines and sufficient supplies for vaccination.
Coronavirus disease.
Latest|The Secretary for Food and Health Approves Kexing Vaccine for emergency use in Hong Kong
New Crown Vaccine | More than 20 vaccination centers will be opened in batches from the end of this month or supplied to Kexing
Vaccine review is a scientific issue and should not be politicized
01News
Coronavirus disease